Growth Metrics

Boston Scientific (BSX) Deferred Taxes (2020 - 2026)

Boston Scientific's Deferred Taxes history spans 7 years, with the latest figure at -$351.0 million for Q1 2026.

  • On a quarterly basis, Deferred Taxes fell 956.1% to -$351.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$404.0 million, a 573.33% decrease, with the full-year FY2025 number at -$12.0 million, up 82.86% from a year prior.
  • Deferred Taxes hit -$351.0 million in Q1 2026 for Boston Scientific, down from -$32.0 million in the prior quarter.
  • Over the last five years, Deferred Taxes for BSX hit a ceiling of $73.0 million in Q4 2023 and a floor of -$351.0 million in Q1 2026.
  • Historically, Deferred Taxes has averaged -$29.2 million across 5 years, with a median of -$11.0 million in 2024.
  • Biggest five-year swings in Deferred Taxes: plummeted 7400.0% in 2022 and later skyrocketed 942.86% in 2023.
  • Tracing BSX's Deferred Taxes over 5 years: stood at $7.0 million in 2022, then skyrocketed by 942.86% to $73.0 million in 2023, then crashed by 209.59% to -$80.0 million in 2024, then surged by 60.0% to -$32.0 million in 2025, then crashed by 996.88% to -$351.0 million in 2026.
  • Business Quant data shows Deferred Taxes for BSX at -$351.0 million in Q1 2026, -$32.0 million in Q4 2025, and $69.0 million in Q3 2025.